Verzending 24–48 u • Levering in de hele EU • Veilige chemieverpakking
Competitive inhibitor of ATP binding to the catalytic domain of tyrosin kinases. Exceptional are the insulin receptor tyrosin kinase and the serin-/threonin specific proteases, which will not be inhibited by genistein. An additional, tyrosin kinase independent, effect of genistein is the inhibition of topoisomerases I and II.
Working concentration: 10-100 µM
| Assay (HPLC) | ≥98 % |
| Heavy metals | ≤0,001 % |
| Loss on drying | ≤1,0 % |

![3-PHENYLIMIDAZO[1,2-A]PYRAZINE, 97.0%, 1g 3-PHENYLIMIDAZO[1,2-A]PYRAZINE, 97.0%, 1g](https://d2j6dbq0eux0bg.cloudfront.net/images/88473019/4861032038.png)
![Tris[2-(methylamino)ethyl]amine, 98%, 250mg Tris[2-(methylamino)ethyl]amine, 98%, 250mg](https://d2j6dbq0eux0bg.cloudfront.net/images/88473019/4771350982.png)
